General Graphene Corporation
General Graphene Corporation is a pioneering advanced materials company specializing in the industrial-scale production of chemical vapor deposition (CVD) graphene and carbon materials. Headquartered in Knoxville, Tennessee, the company leverages proprietary, patented roll-to-roll CVD technology to deliver high-quality, reproducible, and affordable graphene and carbon-based materials at mass volumes. Their mission is to make graphene scalable and accessible for real-world applications, enabling innovation across industries such as electronics, energy storage, life sciences, and more. With a focus on overcoming the traditional limitations of CVD graphene manufacturing, General Graphene supports both research and commercial partners in transitioning graphene from laboratory research to industrial adoption, driving the next wave of material science transformation.
General Graphene Corporation
10239 Cogdill Road Knoxville, TN, USA 37932
What We Do
Single or few-atomic layer graphene films grown on copper foil using proprietary roll-to-roll CVD technology. Available in large-area formats, these films are used in electronics, batteries, sensors, membranes, and more. General Graphene offers CVD graphene films on a variety of substrates tailored to research and application needs.
Porous, three-dimensional structures composed solely of graphene, grown via template-assisted CVD on nickel foam. After etching and rinsing, the result is a freestanding graphene foam with applications in cell culture scaffolds, catalysis electrodes, heat transfer, and drug delivery.
2D carbon films offering low electrical resistance and biocompatibility, suitable for electronics, biosensors, and as disposable electrodes. Produced via CVD directly onto alumina substrates. These films are chemically and thermally stable, and can be deposited on quartz, alumina-based ceramics, and silicon, with applications in electrochemical biosensors, heating elements, chemical barriers, and X-ray imaging.
Infectious Diseases
Digital Health Technologies
Services
Key People
Caleb Townsend
Chris Pagan
Greg Erickson
Founder and CEO
Greg Hayzen
Isaiah Phillips
Ken Bennett
News & Updates
Successfully demonstrated the ability to produce CVD graphene under atmospheric conditions, breaking the traditional vacuum-based limitations.
Commissioned a pilot production line, proving the viability of scalable mass production of CVD graphene under atmospheric conditions.
Launched the third-generation industrial-scale CVD graphene production system, enabling cost-effective, consistent, and reproducible graphene for a range of applications. GG 3.0 is capable of producing between 65,000 and 100,000 sq. meters of roll-to-roll CVD graphene annually at a direct production cost two to three orders of magnitude lower than the market.
Integrated an inline polymer coating system to enable coating of CVD graphene-on-catalyst substrates with thin polymer films, enhancing product versatility.
Developed and implemented a roll-to-roll CVD graphene transfer system, enabling large-area, minimal defect, low chemical footprint transfer of graphene onto polymers.
General Graphene holds a portfolio of more than 25 patents and pending patents related to CVD graphene production and transfer technologies.
An article exploring the properties, forms, and real-world applications of graphene, emphasizing the importance of understanding its nuances for industrial adoption.
Announcement of General Graphene's new online store, providing direct access to industrial-scale CVD-grown monolayer graphene and carbon materials for global researchers and companies.
A discussion on the use of graphene biosensors, inspired by popular culture, and their potential in medical diagnostics and environmental monitoring.
Explores the use of 3D CVD graphene foam as a novel scaffold for high-throughput cell culture, highlighting its biocompatibility and unique properties for regenerative medicine.
Details the technical challenges in transferring large-area CVD graphene films and General Graphene’s advancements in roll-to-roll transfer technology to enable scalable, cost-effective production.
Discusses the advantages of CVD technology for producing high-quality, atomically thin graphene and the process optimizations developed by General Graphene.
Highlights the use of CVD graphene in developing rapid, sensitive diagnostic devices for healthcare applications.
An educational article explaining the structure, properties, and production methods of CVD graphene.
An e-book and article providing an overview of General Graphene’s progress, technology milestones, and the potential of CVD graphene across various industries.
Discusses the importance of scalable, affordable CVD graphene for research and development, and General Graphene’s role in enabling this.
A white paper analyzing the mechanism and commercial potential of CVD graphene field-effect transistor (GFET) biosensors, and General Graphene’s advancements in making them viable at scale.
Describes General Graphene’s advancements in roll-to-roll CVD graphene production and transfer, enabling mass production of graphene-polymer composites at low cost.
Explores the unique properties of CVD graphene for use in various sensor applications, including strain, gas, biosensors, and more.
Examines the history, challenges, and realistic outlook for graphene commercialization, focusing on the need for scalable production.
Analyzes the steps and challenges in transitioning graphene from laboratory research to practical, real-world applications.
Discusses the family of graphene materials, their properties at different scales, and General Graphene’s unique APCVD method for producing both nano- and microscale carbon materials.
Details General Graphene’s patented atmospheric pressure CVD process for producing high-quality graphene sheets in a roll-to-roll format at high volume and low cost.
Gregory Erickson, Founder and CFO, explains the characteristics and versatility of graphene, and how General Graphene's scalable production process enables its integration into a wide range of applications.